medigraphic.com
ISSN 1817-5996 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cub de Reu 2021; 23 (2)

Prolotherapy in knee osteoarthritis

Álvarez LA, Fuentes-Véjar R, Soto-Carrasco SR, García LYC

Language: Spanish
References: 39
Page:
PDF size: 395.89 Kb.


ABSTRACT

Gonarthrosis is a very frequent entity and affects a large group of patients especially above 40 years, conservative treatment is the first line and includes prolotherapy. To update knowledge regarding the use of prolotherapy in patients with gonarthrosis. The information was searched and analyzed over a period of two months (February 1, 2020 to April 30, 2020) and the following words were used: prolotherapy, regenerative injection therapy and chronic musculoskeletal pain. Based on the information obtained, a bibliographic review of a total of 203 articles published in the PubMed, Hinari, SciELO and Medline databases was carried out using the search manager and reference manager EndNote, 39 selected citations were used to make the review, including 32 of the last five years, also consulted a book. The concentrations to be used both intra and periarticular, indications and mechanisms of action are mentioned. The frequency of its application is described, as well as the comparison with other intra-articular treatment methods. Reference is made to the duration of its effect and complications. Prolotherapy by administering intra-articular hypertonic dextrose is a useful method in the treatment of patients with gonarthrosis, its easy application, availability and low complication rate make it a feasible and effective conservative method.


REFERENCES

  1. Vigorita VJ. Orthopaedic Pathology. 3rd ed. Philadelphia: Wolters Kluwer; 2016.

  2. Arias-Vázquez PI, Tovilla-Zárate CA, Legorreta-Ramírez BG, Burad Fonz W, Magaña-Ricardez D, González-Castro TB, et al. Prolotherapy for knee osteoarthritis using hypertonic dextrose vs other interventional treatments: systematic review of clinical trials. Adv Rheumatol. 2019 Aug;59(1):39. DOI: https://doi.org/10.1186/s42358-019-0083-7

  3. Cianca JC, Jayaram P. Musculoskeletal injuries and regenerative medicine in the elderly patient. Phys Med Rehabil Clin N Am. 2017 Nov;28(4):777-94. DOI: https://doi.org/10.1016/j.pmr.2017.06.010

  4. Hosseini B, Taheri M, Pourroustaei Ardekani R, Moradi S, Kazempour Mofrad M. Periarticular hypertonic dextrose vs intraarticular hyaluronic acid injections: A comparison of two minimally invasive techniques in the treatment of symptomatic knee osteoarthritis. Open Access Rheumatol. 2019 Nov;11:269-74. DOI: https://doi.org/10.2147/OARRR.S215576

  5. Reeves KD, Sit RW, Rabago DP. Dextrose prolotherapy: A narrative review of basic science, clinical research, and best treatment recommendations. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):783-823. DOI: https://doi.org/10.1016/j.pmr.2016.06.001

  6. Singh V, Trescot A, Nishio I. Injections for chronic pain. Phys Med Rehabil Clin N Am. 2015 May;26(2):249-61. DOI: https://doi.org/10.1016/j.pmr.2015.01.004

  7. Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani SA. Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. J Pain Res. 2017 May;10:1179-87. DOI: https://doi.org/10.2147/JPR.S127633. eCollection 2017

  8. Chen SH, Kuan TS, Kao MJ, Wu WT, Chou LW. Clinical effectiveness in severe knee osteoarthritis after intra-articular platelet-rich plasma therapy in association with hyaluronic acid injection: three case reports. Clin Interv Aging. 2016 Sep;11:1213-9. DOI: https://doi.org/10.2147/CIA.S114795. eCollection 2016

  9. Sit RW, Chung VCh, Reeves KD, Rabago D, Chan KK, Chan DC, et al. Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: A systematic review and meta-analysis. Sci Rep. 2016 May;6:25247. DOI: https://doi.org/10.1038/srep25247

  10. Sit RWS, Wu RWK, Reeves KD, Rabago D, Chan DCC, Yip BHK, et al. Efficacy of intra-articular hypertonic dextrose prolotherapy versus normal saline for knee osteoarthritis: a protocol for a triple-blinded randomized controlled trial. BMC Complement Altern Med. 2018 May;18(1):157. DOI: https://doi.org/10.1370/afm.2520

  11. Krsticevic M, Jeric M, Došenovic S, Jelicic Kadic A, Puljak L. Proliferative injection therapy for osteoarthritis: a systematic review. Int Orthop. 2017 Apr;41(4):671-9. DOI: https://doi.org/10.1007/s00264-017-3422-5

  12. Tieppo Francio V, Dima RS, Towery C, Davani S. Prolotherapy and low level laser therapy: a synergistic approach to pain management in chronic osteoarthritis. Anesth Pain Med. 2017 Oct;7(5):e14470. DOI: https://doi.org/10.5812/aapm.14470

  13. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016 Jul;9:139-59. DOI: https://doi.org/10.4137/CMAMD.S39160

  14. Hassan F, Murrell WD, Refalo A, Maffulli N. Alternatives to biologics in management of knee osteoarthritis: A systematic review. Sports Med Arthrosc Rev. 2018 Jun;26(2):79-85. DOI: 10.1097/JSA.0000000000000190

  15. Covey CJ, Sineath MH Jr, Penta JF, Leggit JC. Prolotherapy: can it help your patient? J Fam Pract. 2015 Dec [Acceso 01/02/2020];64(12):763-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26844994/

  16. Isik R, Karapolat H, Bayram KB, Usan H, Tanigör G, Atamaz Çalis F. Effects of short wave diathermy added on dextrose prolotherapy injections in osteoarthritis of the knee. J Altern Complement Med. 2020 Apr;26(4):316-22. DOI: https://doi.org/10.1089/acm.2019.0341

  17. Poddar SK, Widstrom L. Nonoperative options for management of articular cartilage disease. Clin Sports Med. 2017 Jul;36(3):447-56. DOI: https://doi.org/10.1016/j.csm.2017.02.003

  18. Farpour HR, Fereydooni F. Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: a randomized clinical trial. Electron Physician. 2017 Nov;9(11):5663-9. DOI: https://doi.org/10.19082/5663

  19. Hulsopple C. Musculoskeletal therapies: musculoskeletal injection therapy. FP Essent. 2018 Jul [Acceso 30/04/2020];470:21-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29963845/

  20. Russell SJ, Sala R, Conaghan PG, Habib G, Vo Q, Manning R, et al. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: A randomized, phase 2 study. Rheumatology (Oxford). 2018 Dec;57(12):2235-41. DOI: https://doi.org/10.1093/rheumatology/key265

  21. Eslamian F, Amouzandeh B. Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: A single-arm study with 6 months follow up. Ther Adv Musculoskelet Dis. 2015 Apr;7(2):35-44. DOI: https://doi.org/10.1177/1759720X14566618

  22. Sert AT, Ozcan E, Esmaeilzadeh S. Poster 383 effects of dextrose prolotherapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial. PMR. 2016 Sep;8(9S):S286. DOI: https://doi.org/10.1016/j.pmrj.2016.07.310

  23. Shan Sit RW, Keung Wu RW, Rabago D, Reeves KD, Chun Chan DC, Kei Yip BH, et al. Efficacy of intra-articular hypertonic dextrose (prolotherapy) for knee osteoarthritis: A randomized controlled trial. Ann Fam Med. 2020 May;18(3):235-42. DOI: https://doi.org/10.1370/afm.2520

  24. Driban JB, Eaton CB, Amin M, Stout AC, Price LL, Lu B, et al. Glucose homeostasis influences the risk of incident knee osteoarthritis: data from the osteoarthritis initiative. J Orthop Res. 2017 Oct;35(10):2282-7. DOI: https://doi.org/10.1002/jor.23531

  25. Sert AT, Sen EI, Esmaeilzadeh S, Ozcan E. The effects of dextrose prolotherapy in symptomatic knee osteoarthritis: a randomized controlled study. J Altern Complement Med. 2020 May;26(5):409-17. DOI: https://doi.org/10.1089/acm.2019.0335

  26. Hung CY, Hsiao MY, Chang KV, Han DS, Wang TG. Comparative effectiveness of dextrose prolotherapy versus control injections and exercise in the management of osteoarthritis pain: A systematic review and meta-analysis. J Pain Res. 2016 Oct;9:847-57. DOI: https://doi.org/10.2147/JPR.S118669

  27. Rabago D, Nourani B. Prolotherapy for osteoarthritis and tendinopathy: A descriptive review. Curr Rheumatol Rep. 2017 Jun;19(6):34. DOI: https://doi.org/10.1016/j.pmr.2019.07.003

  28. Hassan F, Trebinjac S, Murrell WD, Maffulli N. The effectiveness of prolotherapy in treating knee osteoarthritis in adults: a systematic review. Br Med Bull. 2017 Jun;122(1):91-108. DOI: https://doi.org/10.1093/bmb/ldx006

  29. Rabago D, Reeves KD, Doherty MP, Fleck M. Prolotherapy for musculoskeletal pain and disability in low- and middle-income countries. Phys Med Rehabil Clin N Am. 2019 Nov;30(4):775-786. DOI: https://doi.org/10.1016/j.pmr.2019.07.003

  30. Topol GA, Podesta LA, Reeves KD, Giraldo MM, Johnson LL, Grasso R, et al. Chondrogenic effect of intra-articular hypertonic-dextrose (Prolotherapy) in severe knee osteoarthritis. PMR. 2016 Nov;8(11):1072-82. DOI: https://doi.org/10.1016/j.pmrj.2016.03.008

  31. Rabago D, van Leuven L, Benes L, Fortney L, Slattengren A, Grettie J, et al. Qualitative assessment of patients receiving prolotherapy for knee osteoarthritis in a multimethod study. J Altern Complement Med. 2016 Dec;22(12):983-9. DOI: https://doi.org/10.1089/acm.2016.0164

  32. Rabago D, Kansariwala I, Marshall D, Nourani B, Stiffler-Joachim M, Heiderscheit B. Dextrose prolotherapy for symptomatic knee osteoarthritis: feasibility, acceptability, and patient-oriented outcomes in a pilot-level quality improvement project. J Altern Complement Med. 2019 Apr;25(4):406-12. DOI: https://doi.org/10.1089/acm.2018.0361

  33. Reeves KD, Hassanein K. Randomized prospective double blind placebo controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000 Mar;6(2)68-74.

  34. Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, et al. Dextrose prolotherapy for knee osteoarthritis: A randomized controlled trial. Ann Fam Med. 2013 May-Jun;11(3):229-37. DOI: https://doi.org/10.1370/afm.1504

  35. Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, Zgierska A, et al. Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis. Arch Phys Med Rehabil. 2013 Nov;94(11):2075-82. DOI: https://doi.org/10.1016/j.apmr.2013.06.025

  36. Hashemi SM, Madadi F, Razavi S, Nikooseresht M, Kibabi FH, Nasiripour S. Intra-articular hyaluronic acid injections vs dextrose prolotherapy in the treatment of osteoarthritic knee pain. Tehran University Med J. 2012 Feb;70(2):119-25. DOI: https://doi.org/10.5812/aapm.27585

  37. Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F, et al. The effects of prolotherapy with hypertonic dextrose versus prolozone (intraarticular Ozone) in patients with knee osteoarthritis. Anesth Pain Med. 2015 Oct;5(5):e27585. DOI: https://doi.org/10.5812/aapm.27585

  38. Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging. 2018 Jan;13:73-79. DOI: https://doi.org/10.1186/s42358-019-0083-7

  39. Rahimzadeh P, Imani F, Faiz SH, Entezary SR, Nasiri AA, Ziaeefard M. Investigation the efficacy of intra-articular prolotherapy with erythropoietin and dextrose and intra-articular pulsed radiofrequency on pain level reduction and range of motion improvement in primary osteoarthritis of knee. J Res Med Sci. 2014 Aug [Acceso 30/04/2020];19(8):696-702. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25422652/




2020     |     www.medigraphic.com